
Impact of type 2 diabetes on adenoma detection in screening colonoscopies performed in disparate populations
Author(s) -
Dimitri Joseph,
Ellen Li,
Samuel L. Stanley,
Yicong Zhu,
Xiaoning Li,
Jie Yang,
Lorenzo F. Ottaviano,
Juan Carlos Bucobo,
Jonathan M. Buscaglia,
Joshua D. Miller,
Rajesh Veluvolu,
Michele Follen,
Evan Grossman
Publication year - 2021
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v9.i11.2433
Subject(s) - medicine , type 2 diabetes , adenoma , diabetes mellitus , colonoscopy , colorectal cancer screening , general surgery , colorectal cancer , endocrinology , cancer
The Black/African Ancestry (AA) population has a higher prevalence of type 2 diabetes mellitus (T2DM) and a higher incidence and mortality rate for colorectal cancer (CRC) than all other races in the United States. T2DM has been shown to increase adenoma risk in predominantly white/European ancestry (EA) populations, but the effect of T2DM on adenoma risk in Black/AA individuals is less clear. We hypothesize that T2DM has a significant effect on adenoma risk in a predominantly Black/AA population.